Compliance

3 Homeopathic Compliance Hot Spots to Watch

All drug products, homeopathic and allopathic alike, must be safe and effective. That means they have to be manufactured correctly, containing only the ingredients and potencies they claim to have. In short, all drugs must comply with Current Good Manufacturing Practice (CGMP). It is not only FDA’s responsibility to ensure these medications fulfill the CGMP requirements of safety, identity, strength, quality, and purity—it’s the industry’s responsibility, too.

Read More

How to Submit Monographs to the HPUS

FDA’s Revised Draft Enforcement Document states the Agency considers only products that use substances monographed in the Homeopathic Pharmacopeia of the United States (HPUS) as homeopathic. This statement has created interest in what steps are necessary to submit a monograph to the Homeopathic Pharmacopeia Convention of the United States (HPCUS) for readm more…

Read More

AAHP 2019: Reawakening the Regulatory and Retail Dialog

By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for the industry as an advocate and representative over the entire duration. In 2019 AAHP provided direction and regulatory thought-leadership within readm more…

Read More

4 Types of FDA Inspections & How to Prepare

Risk. It’s a hot word in the homeopathic industry right now. Even before the FDA issued its draft guidance, the agency used a risk-based approach to site inspections. With the 2012 Safety and Innovation Act, the agency nixed a set inspection calendar and began visiting manufacturers “in accordance with a readm more…

Read More

Little-Known Facts About 3 Unique Starting Materials

By Mary Beth Watkins and Eric Foxman   The array of substances used for homeopathic drug products is wide and varied. Many homeopathic starting materials also have uses outside of our industry and might be familiar by their common English names. We’ve reformatted “Drug Facts” panels to give you several readm more…

Read More

Clearing the Air: Consider Slack-Fill

By Mark Land, AAHP President   Although the term might not be familiar, you may have been fooled by “slack-fill” as a consumer of many types of products at one time in your past. It’s the difference between the actual capacity of a container and the volume of the product readm more…

Read More

Your Products Might Require Child-Resistant Packaging Statements

If so, they must comply with both CPSC and FDA requirements. Consumer Product Safety Commission (CPSC) Requirements CPSC is responsible for enforcing the Poison Prevention Packaging Act (PPPA). Introduced in 1970, PPPA is intended to protect children, under five years of age, from unintentional exposure to household substances. PPPA features readm more…

Read More

Alert: FDA Drug Listing Records Subject to Inactivation

By Eric Foxman, AAHP Secretary   Beginning September 14, 2019, and every January, FDA will begin to inactivate drug listings that are uncertified in the previous renewal period. Last month, the Food and Drug Administration (FDA) announced that it intends to inactivate drug listing records that are a) not certified readm more…

Read More